Novartis, Sarepta partner with new George Church gene therapy startup

Dyno Therapeutics launched Monday with plans to use artificial intelligence to expand the use of gene therapy.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.